Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
January 31, 2023
Patent Application Number
17123366
Date Filed
December 16, 2020
Patent Citations
Patent Primary Examiner
The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and/or a SGLT-2 inhibitor drug, and metformin XR, processes for the preparation thereof, and their use to treat certain diseases.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
